We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MTNB market cap is 2.87M. The company's latest EPS is USD -4.5099 and P/E is -0.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.13M | -5.89M | -5.9M | -5.84M | -4.38M |
| Net Income | -6.06M | -5.31M | -5.82M | -5.72M | -4.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 90k | 158k | 33k | 3.19M | 1.1M |
| Operating Income | -18.92M | -24.21M | -24.74M | -24.59M | -23.77M |
| Net Income | -18.3M | -23.24M | -23.68M | -21M | -22.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.79M | 25.1M | 19.61M | 24.37M | 20.58M |
| Total Liabilities | 6.64M | 5.86M | 5.05M | 5.26M | 4.8M |
| Total Equity | 23.15M | 19.25M | 14.56M | 19.1M | 15.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.24M | 70.97M | 61.33M | 44.82M | 25.1M |
| Total Liabilities | 7.19M | 7.24M | 8.83M | 8.18M | 5.86M |
| Total Equity | 33.05M | 63.73M | 52.49M | 36.64M | 19.25M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.7M | -15.28M | -5.77M | -8.88M | -12.38M |
| Investing | 10.28M | 13.24M | 2M | -938k | 8.71M |
| Financing | -6k | -7k | 53k | 9.24M | 9.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.09M | -17.37M | -15.22M | -19.16M | -15.28M |
| Investing | -6.01M | -40.67M | 16.77M | 4.88M | 13.24M |
| Financing | 29.85M | 48.05M | 6.97M | 79k | -7k |
| Market Cap | 2.87M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 2.6 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 5.09M |
| Average Volume (1 week) | 283.18k |
| Average Volume (1 Month) | 1.18M |
| 52 Week Change | -94.21% |
| 52 Week High | 21.50 |
| 52 Week Low | 0.478 |
| Spread (Intraday) | 0.07 (10.63%) |
| Company Name | Matinas Biopharma Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.matinasbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
